This work is licensed under a Creative Commons Attribution 4.0 International License.
Y4eK_21-BH3
General Information
DRACP ID DRACP03034
Peptide Name Y4eK_21-BH3
Sequence RPEIWYAQGLKRFGDEFNAYK
Sequence Length 21
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Induce apoptosis Bcl-xL inhibitors BH3 peptides and mimetics
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| MDA-MB-231 (Bc1-xL dependent) | Breast adenocarcinoma | Carcinoma | EC50=159 ± 53 nM | Not available | Not available | 1 |
| OCI-Ly1 (Bcl-2 dependent) | Diffuse large B-cell lymphoma | Lymphoma | EC50=3.435 ± 0.839 μM | Not available | Not available | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Bcl-xL
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C121H174N32O32
Absent amino acids CHMSTV
Common amino acids AEFGKRY
Mass 294582
Pl 9.12
Basic residues 4
Acidic residues 3
Hydrophobic residues 7
Net charge 1
Boman Index -5211
Hydrophobicity -108.1
Aliphatic Index 46.67
Half Life
Mammalian: 20 hour
Yeast: 30 min
E.coli: >10 hour
Extinction Coefficient cystines 8480
Absorbance 280nm 424
Polar residues 5
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 25451027
Title Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL
Year 2015
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.